Tumores neuroendocrinos: impacto de LANREÓTIDA en la supervivencia de la enfermedad estable y progresiva - page 16

CLARINET OPEN LABEL EXTENSION STUDY:

Primary / Grade / Tumor burden

Caplin M, et al.

ENETS

2015

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,6,7,8,9,10,11,12,13,14,15 17,18,19,20,21,22,23,24,25,...26